Zobrazeno 1 - 10 of 120 pro vyhledávání: '"Torres-Ramón I"'
1
Akademický článek
Peripheral Blood TCRβ Repertoire, IL15, IL2 and Soluble Ligands for NKG2D Activating Receptor Predict Efficacy of Immune Checkpoint Inhibitors in Lung Cancer.
Autor: Sesma A; Medical Oncology Department, University Hospital Lozano Blesa, 50009 Zaragoza, Spain.; Aragon Health Research Institute (IIS Aragón), 50009 Zaragoza, Spain., Pardo J; Aragon Health Research Institute (IIS Aragón), 50009 Zaragoza, Spain.; CIBER de Enfermedades Infecciosas (CIBERINFEC), 28029 Madrid, Spain.; Microbiology, Radiology, Pediatry and Public Health Department Medicine, University of Zaragoza, 50009 Zaragoza, Spain., Isla D; Medical Oncology Department, University Hospital Lozano Blesa, 50009 Zaragoza, Spain.; Aragon Health Research Institute (IIS Aragón), 50009 Zaragoza, Spain., M Gálvez E; CIBER de Enfermedades Infecciosas (CIBERINFEC), 28029 Madrid, Spain.; Instituto de Carboquímica (ICB-CSIC), Miguel Luesma 4, 50018 Zaragoza, Spain., Gascón-Ruiz M; Medical Oncology Department, University Hospital Lozano Blesa, 50009 Zaragoza, Spain.; Aragon Health Research Institute (IIS Aragón), 50009 Zaragoza, Spain., Martínez-Lostao L; Aragon Health Research Institute (IIS Aragón), 50009 Zaragoza, Spain.; Department of Microbiology, Pediatrics, Radiology and Public Health, University of Zaragoza, 50009 Zaragoza, Spain.; Aragon Nanoscience Institute, 50018 Zaragoza, Spain.; Aragon Materials Science Institute, 50009 Zaragoza, Spain.; Immunology Department, University Hospital Lozano Blesa, 50009 Zaragoza, Spain., Moratiel A; Medical Oncology Department, University Hospital Lozano Blesa, 50009 Zaragoza, Spain.; Aragon Health Research Institute (IIS Aragón), 50009 Zaragoza, Spain., Paño-Pardo JR; Aragon Health Research Institute (IIS Aragón), 50009 Zaragoza, Spain.; CIBER de Enfermedades Infecciosas (CIBERINFEC), 28029 Madrid, Spain.; Infectious Disease Department, University Hospital Lozano Blesa, 50009 Zaragoza, Spain., Quílez E; Medical Oncology Department, University Hospital Lozano Blesa, 50009 Zaragoza, Spain.; Aragon Health Research Institute (IIS Aragón), 50009 Zaragoza, Spain., Torres-Ramón I; Medical Oncology Department, University Hospital Lozano Blesa, 50009 Zaragoza, Spain.; Aragon Health Research Institute (IIS Aragón), 50009 Zaragoza, Spain., Yubero A; Medical Oncology Department, University Hospital Lozano Blesa, 50009 Zaragoza, Spain.; Aragon Health Research Institute (IIS Aragón), 50009 Zaragoza, Spain., Zapata-García M; Medical Oncology Department, University Hospital Lozano Blesa, 50009 Zaragoza, Spain.; Aragon Health Research Institute (IIS Aragón), 50009 Zaragoza, Spain., Domingo MP; Immunology Department, University Hospital Lozano Blesa, 50009 Zaragoza, Spain., Esteban P; Aragon Health Research Institute (IIS Aragón), 50009 Zaragoza, Spain., Sanz Pamplona R; Aragon Health Research Institute (IIS Aragón), 50009 Zaragoza, Spain., Lastra R; Medical Oncology Department, University Hospital Lozano Blesa, 50009 Zaragoza, Spain.; Aragon Health Research Institute (IIS Aragón), 50009 Zaragoza, Spain., Ramírez-Labrada A; Aragon Health Research Institute (IIS Aragón), 50009 Zaragoza, Spain.; CIBER de Enfermedades Infecciosas (CIBERINFEC), 28029 Madrid, Spain.
Publikováno v: Cancers [Cancers (Basel)] 2024 Aug 08; Vol. 16 (16). Date of Electronic Publication: 2024 Aug 08.
Zobrazit plný text záznamu
2
Akademický článek
Impact of antibiotics, corticosteroids, and microbiota on immunotherapy efficacy in patients with non-small cell lung cancer.
Autor: Zapata-García M; Medical Oncology Department, Lozano Blesa University Hospital Clinic, 50009, Zaragoza, Spain.; Health Research Institute of Aragón (IIS Aragón), 50009, Zaragoza, Spain., Moratiel-Pellitero A; Medical Oncology Department, Lozano Blesa University Hospital Clinic, 50009, Zaragoza, Spain., Isla D; Medical Oncology Department, Lozano Blesa University Hospital Clinic, 50009, Zaragoza, Spain.; Health Research Institute of Aragón (IIS Aragón), 50009, Zaragoza, Spain., Gálvez E; Institute of Carbochemistry (ICB-CSIC), Zaragoza, Spain.; Center for Biomedical Research in the Network of Infectious Diseases (CIBERINFEC), Carlos III Health Institute (ISCIII), Madrid, Spain., Gascón-Ruiz M; Health Research Institute of Aragón (IIS Aragón), 50009, Zaragoza, Spain.; Medical Oncology Department, Miguel Servet University Hospital, 50009, Zaragoza, Spain., Sesma A; Health Research Institute of Aragón (IIS Aragón), 50009, Zaragoza, Spain.; Medical Oncology Department, Miguel Servet University Hospital, 50009, Zaragoza, Spain., Barbero R; Microbiology Department, Ramón y Cajal University Hospital and IRYCIS, Madrid, Spain., Galeano J; Complex Systems Group, Universidad Politécnica de Madrid, Madrid, Spain., Del Campo R; Center for Biomedical Research in the Network of Infectious Diseases (CIBERINFEC), Carlos III Health Institute (ISCIII), Madrid, Spain.; Microbiology Department, Ramón y Cajal University Hospital and IRYCIS, Madrid, Spain., Ocáriz M; Medical Oncology Department, Lozano Blesa University Hospital Clinic, 50009, Zaragoza, Spain., Quílez E; Medical Oncology Department, Lozano Blesa University Hospital Clinic, 50009, Zaragoza, Spain.; Health Research Institute of Aragón (IIS Aragón), 50009, Zaragoza, Spain., Cruellas M; Medical Oncology Department, Vall d'Hebrón University Hospital, 08035, Barcelona, Spain., Remírez-Labrada A; Health Research Institute of Aragón (IIS Aragón), 50009, Zaragoza, Spain., Pardo J; Health Research Institute of Aragón (IIS Aragón), 50009, Zaragoza, Spain.; Center for Biomedical Research in the Network of Infectious Diseases (CIBERINFEC), Carlos III Health Institute (ISCIII), Madrid, Spain.; Microbiology Department, Preventive Medicine and Public Health, University of Zaragoza, 50009, Zaragoza, Spain., Martínez-Lostao L; Microbiology Department, Preventive Medicine and Public Health, University of Zaragoza, 50009, Zaragoza, Spain., Domingo MP; Institute of Carbochemistry (ICB-CSIC), Zaragoza, Spain., Esteban P; Health Research Institute of Aragón (IIS Aragón), 50009, Zaragoza, Spain., Torres-Ramón I; Medical Oncology Department, Lozano Blesa University Hospital Clinic, 50009, Zaragoza, Spain.; Health Research Institute of Aragón (IIS Aragón), 50009, Zaragoza, Spain., Yubero A; Medical Oncology Department, Lozano Blesa University Hospital Clinic, 50009, Zaragoza, Spain.; Health Research Institute of Aragón (IIS Aragón), 50009, Zaragoza, Spain., Paño JR; Health Research Institute of Aragón (IIS Aragón), 50009, Zaragoza, Spain.; ESCMID Fellow, Infectious Diseases Department, Lozano Blesa University Hospital Clinic, Zaragoza, Spain and University of Zaragoza, 50009, Zaragoza, Spain., Lastra R; Medical Oncology Department, Lozano Blesa University Hospital Clinic, 50009, Zaragoza, Spain.; Health Research Institute of Aragón (IIS Aragón), 50009, Zaragoza, Spain.
Publikováno v: Heliyon [Heliyon] 2024 Jul 01; Vol. 10 (13), pp. e33684. Date of Electronic Publication: 2024 Jul 01 (Print Publication: 2024).
Zobrazit plný text záznamu
3
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
4
Akademický článek
Comparation of different malnutrition screening tools according to GLIM criteria in cancer outpatients.
Autor: Gascón-Ruiz M; Medical Oncology Department, University Hospital Lozano Blesa, Av. San Juan Bosco 15, 50009, Zaragoza, Spain. marta.gascon6@gmail.com.; Instituto de Investigación Sanitaria (IIS) Aragón, Av. San Juan Bosco, 13, 50009, Zaragoza, Spain. marta.gascon6@gmail.com., Casas-Deza D; Instituto de Investigación Sanitaria (IIS) Aragón, Av. San Juan Bosco, 13, 50009, Zaragoza, Spain.; Gastroenterology and Hepatology Department, University Hospital Miguel Servet, Av. Isabel la Católica 1-3, 50009, Zaragoza, Spain., Torres-Ramón I; Medical Oncology Department, University Hospital Lozano Blesa, Av. San Juan Bosco 15, 50009, Zaragoza, Spain.; Instituto de Investigación Sanitaria (IIS) Aragón, Av. San Juan Bosco, 13, 50009, Zaragoza, Spain., Zapata-García M; Medical Oncology Department, University Hospital Lozano Blesa, Av. San Juan Bosco 15, 50009, Zaragoza, Spain.; Instituto de Investigación Sanitaria (IIS) Aragón, Av. San Juan Bosco, 13, 50009, Zaragoza, Spain., Alonso N; Medical Oncology Department, University Hospital Lozano Blesa, Av. San Juan Bosco 15, 50009, Zaragoza, Spain.; Instituto de Investigación Sanitaria (IIS) Aragón, Av. San Juan Bosco, 13, 50009, Zaragoza, Spain., Sesma A; Medical Oncology Department, University Hospital Lozano Blesa, Av. San Juan Bosco 15, 50009, Zaragoza, Spain.; Instituto de Investigación Sanitaria (IIS) Aragón, Av. San Juan Bosco, 13, 50009, Zaragoza, Spain., Lambea J; Medical Oncology Department, University Hospital Lozano Blesa, Av. San Juan Bosco 15, 50009, Zaragoza, Spain.; Instituto de Investigación Sanitaria (IIS) Aragón, Av. San Juan Bosco, 13, 50009, Zaragoza, Spain., Álvarez-Alejandro M; Medical Oncology Department, University Hospital Lozano Blesa, Av. San Juan Bosco 15, 50009, Zaragoza, Spain.; Instituto de Investigación Sanitaria (IIS) Aragón, Av. San Juan Bosco, 13, 50009, Zaragoza, Spain., Quílez E; Medical Oncology Department, University Hospital Lozano Blesa, Av. San Juan Bosco 15, 50009, Zaragoza, Spain.; Instituto de Investigación Sanitaria (IIS) Aragón, Av. San Juan Bosco, 13, 50009, Zaragoza, Spain., Isla D; Medical Oncology Department, University Hospital Lozano Blesa, Av. San Juan Bosco 15, 50009, Zaragoza, Spain.; Instituto de Investigación Sanitaria (IIS) Aragón, Av. San Juan Bosco, 13, 50009, Zaragoza, Spain., Arbonés-Mainar JM; Instituto de Investigación Sanitaria (IIS) Aragón, Av. San Juan Bosco, 13, 50009, Zaragoza, Spain.; Translational Research Unit, Miguel Servet University Hospital, Instituto Aragonés de Ciencias de la Salud (IACS), Av. Isabel la Católica 1-3, 50009, Zaragoza, Spain.; Biomedical Research Center in Physiopathology of Obesity and Nutrition (CIBERObn), Health Institute Carlos III (ISCIII), Av. Monforte de Lemos, 3-5, 28029, Madrid, Spain.
Publikováno v: European journal of clinical nutrition [Eur J Clin Nutr] 2022 May; Vol. 76 (5), pp. 698-702. Date of Electronic Publication: 2021 Oct 07.
Zobrazit plný text záznamu
5
From tumor mutational burden to blood T cell receptor: Looking for the best predictive biomarker in lung cancer treated with immunotherapy
Autor: Sesma, A., Pardo, J., Cruellas, M., Gálvez, E.M., Gascón, M., Isla, D., Martínez-Lostao, L., Ocáriz, M., Paño, J.R., Quílez, E., Ramírez, A., Torres-Ramón, I., Yubero, A., Zapata, M., Lastra, R.
Publikováno v: Digital.CSIC. Repositorio Institucional del CSIC
instname
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Zaguán: Repositorio Digital de la Universidad de Zaragoza
Universidad de Zaragoza
2 tables. Immune control inhibitor drugs (anti-PD1/PD-L1/CTLA-4) (ICIs) are showing efficacy in the treatment of lung cancer. Currently the only biomarker with clinical utility for ICIs, such as the expression of PDL1, does not appear to be perfect o
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::865e026b8b0d0186a2b29672a95ed964
http://hdl.handle.net/10261/221775
Zobrazit plný text záznamu
6
Akademický článek
A Subset of PD-1-Expressing CD56 bright NK Cells Identifies Patients with Good Response to Immune Checkpoint Inhibitors in Lung Cancer.
Autor: Gascón-Ruiz M; Medical Oncology Department, University Hospital Lozano Blesa, 50009 Zaragoza, Spain.; Aragon Health Research Institute (IIS Aragón), 50009 Zaragoza, Spain., Ramírez-Labrada A; Nanotoxicology and Immunotoxicology Unit (IIS Aragón), 50009 Zaragoza, Spain.; CIBER de Enfermedades Infecciosas (CIBERINFEC), 28029 Madrid, Spain., Lastra R; Medical Oncology Department, University Hospital Lozano Blesa, 50009 Zaragoza, Spain.; Aragon Health Research Institute (IIS Aragón), 50009 Zaragoza, Spain., Martínez-Lostao L; Aragon Health Research Institute (IIS Aragón), 50009 Zaragoza, Spain.; Immunology Department, University Hospital Lozano Blesa, 50009 Zaragoza, Spain.; Department of Microbiology, Pediatrics, Radiology and Public Health, University of Zaragoza, 50009 Zaragoza, Spain.; Aragon Nanoscience Institute, 50018 Zaragoza, Spain.; Aragon Materials Science Institute, 50009 Zaragoza, Spain., Paño-Pardo JR; Aragon Health Research Institute (IIS Aragón), 50009 Zaragoza, Spain.; CIBER de Enfermedades Infecciosas (CIBERINFEC), 28029 Madrid, Spain.; Infectious Disease Department, University Hospital Lozano Blesa, 50009 Zaragoza, Spain., Sesma A; Medical Oncology Department, University Hospital Lozano Blesa, 50009 Zaragoza, Spain.; Aragon Health Research Institute (IIS Aragón), 50009 Zaragoza, Spain., Zapata-García M; Medical Oncology Department, University Hospital Lozano Blesa, 50009 Zaragoza, Spain.; Aragon Health Research Institute (IIS Aragón), 50009 Zaragoza, Spain., Moratiel A; Medical Oncology Department, University Hospital Lozano Blesa, 50009 Zaragoza, Spain.; Aragon Health Research Institute (IIS Aragón), 50009 Zaragoza, Spain., Quílez E; Medical Oncology Department, University Hospital Lozano Blesa, 50009 Zaragoza, Spain.; Aragon Health Research Institute (IIS Aragón), 50009 Zaragoza, Spain., Torres-Ramón I; Medical Oncology Department, University Hospital Lozano Blesa, 50009 Zaragoza, Spain.; Aragon Health Research Institute (IIS Aragón), 50009 Zaragoza, Spain., Yubero A; Medical Oncology Department, University Hospital Lozano Blesa, 50009 Zaragoza, Spain.; Aragon Health Research Institute (IIS Aragón), 50009 Zaragoza, Spain., Domingo MP; Instituto de Carboquímica (ICB-CSIC), Miguel Luesma 4, 50018 Zaragoza, Spain., Esteban P; Aragon Health Research Institute (IIS Aragón), 50009 Zaragoza, Spain., Gálvez EM; CIBER de Enfermedades Infecciosas (CIBERINFEC), 28029 Madrid, Spain.; Instituto de Carboquímica (ICB-CSIC), Miguel Luesma 4, 50018 Zaragoza, Spain., Pardo J; Aragon Health Research Institute (IIS Aragón), 50009 Zaragoza, Spain.; CIBER de Enfermedades Infecciosas (CIBERINFEC), 28029 Madrid, Spain.; Microbiology, Radiology, Pediatry and Public Health Department Medicine, University of Zaragoza, 50009 Zaragoza, Spain., Isla D; Medical Oncology Department, University Hospital Lozano Blesa, 50009 Zaragoza, Spain.; Aragon Health Research Institute (IIS Aragón), 50009 Zaragoza, Spain.
Publikováno v: Cancers [Cancers (Basel)] 2023 Jan 04; Vol. 15 (2). Date of Electronic Publication: 2023 Jan 04.
Zobrazit plný text záznamu
7
Akademický článek
Diagnosis of Malnutrition According to GLIM Criteria Predicts Complications and 6-Month Survival in Cancer Outpatients.
Autor: Gascón-Ruiz M; Medical Oncology Department, University Hospital Lozano Blesa, Av San Juan Bosco 15, 50009 Zaragoza, Spain.; Instituto de Investigación Sanitaria (IIS) de Aragón, Paseo Isabel la Católica 1-3, 50009 Zaragoza, Spain., Casas-Deza D; Instituto de Investigación Sanitaria (IIS) de Aragón, Paseo Isabel la Católica 1-3, 50009 Zaragoza, Spain.; Gastroenterology and Hepatology Department, University Hospital Miguel Servet, Paseo Isabel la Católica 1-3, 50009 Zaragoza, Spain., Marti-Pi M; Medical Oncology Department, University Hospital Lozano Blesa, Av San Juan Bosco 15, 50009 Zaragoza, Spain., Torres-Ramón I; Medical Oncology Department, University Hospital Lozano Blesa, Av San Juan Bosco 15, 50009 Zaragoza, Spain.; Instituto de Investigación Sanitaria (IIS) de Aragón, Paseo Isabel la Católica 1-3, 50009 Zaragoza, Spain., Zapata-García M; Medical Oncology Department, University Hospital Lozano Blesa, Av San Juan Bosco 15, 50009 Zaragoza, Spain.; Instituto de Investigación Sanitaria (IIS) de Aragón, Paseo Isabel la Católica 1-3, 50009 Zaragoza, Spain., Sesma A; Medical Oncology Department, University Hospital Lozano Blesa, Av San Juan Bosco 15, 50009 Zaragoza, Spain.; Instituto de Investigación Sanitaria (IIS) de Aragón, Paseo Isabel la Católica 1-3, 50009 Zaragoza, Spain., Lambea J; Medical Oncology Department, University Hospital Lozano Blesa, Av San Juan Bosco 15, 50009 Zaragoza, Spain.; Instituto de Investigación Sanitaria (IIS) de Aragón, Paseo Isabel la Católica 1-3, 50009 Zaragoza, Spain., Álvarez-Alejandro M; Medical Oncology Department, University Hospital Lozano Blesa, Av San Juan Bosco 15, 50009 Zaragoza, Spain.; Instituto de Investigación Sanitaria (IIS) de Aragón, Paseo Isabel la Católica 1-3, 50009 Zaragoza, Spain., Quilez E; Medical Oncology Department, University Hospital Lozano Blesa, Av San Juan Bosco 15, 50009 Zaragoza, Spain.; Instituto de Investigación Sanitaria (IIS) de Aragón, Paseo Isabel la Católica 1-3, 50009 Zaragoza, Spain., Isla D; Medical Oncology Department, University Hospital Lozano Blesa, Av San Juan Bosco 15, 50009 Zaragoza, Spain.; Instituto de Investigación Sanitaria (IIS) de Aragón, Paseo Isabel la Católica 1-3, 50009 Zaragoza, Spain., Arbonés-Mainar JM; Instituto de Investigación Sanitaria (IIS) de Aragón, Paseo Isabel la Católica 1-3, 50009 Zaragoza, Spain.; Translational Research Unit, University Hospital Miguel Servet, Instituto Aragonés de Ciencias de la Salud (IACS), Paseo Isabel la Católica 1-3, 50009 Zaragoza, Spain.; Biomedical Research Center in Physiopathology of Obesity and Nutrition (CIBERon), Health Institute Carlos III (ISCIII), Av. Monforte de Lemos, 3-5, 28029 Madrid, Spain.
Publikováno v: Biomedicines [Biomedicines] 2022 Sep 06; Vol. 10 (9). Date of Electronic Publication: 2022 Sep 06.
Zobrazit plný text záznamu
9
Akademický článek
How Could Antibiotics, Probiotics, and Corticoids Modify Microbiota and Its Influence in Cancer Immune Checkpoint Inhibitors: A Review.
Autor: Cruellas M; Medical Oncology Department, University Hospital Lozano Blesa, Zaragoza, Spain.; Aragon Health Research Institute (IIS Aragón), Zaragoza, Spain., Yubero A; Medical Oncology Department, University Hospital Lozano Blesa, Zaragoza, Spain.; Aragon Health Research Institute (IIS Aragón), Zaragoza, Spain., Zapata M; Medical Oncology Department, University Hospital Lozano Blesa, Zaragoza, Spain.; Aragon Health Research Institute (IIS Aragón), Zaragoza, Spain., Galvez EM; Carbochemical Institute (ICB-CSIC), Zaragoza, Spain., Gascón M; Medical Oncology Department, University Hospital Lozano Blesa, Zaragoza, Spain.; Aragon Health Research Institute (IIS Aragón), Zaragoza, Spain., Isla D; Medical Oncology Department, University Hospital Lozano Blesa, Zaragoza, Spain.; Aragon Health Research Institute (IIS Aragón), Zaragoza, Spain., Lastra R; Medical Oncology Department, University Hospital Lozano Blesa, Zaragoza, Spain.; Aragon Health Research Institute (IIS Aragón), Zaragoza, Spain., Martínez-Lostao L; Aragon Health Research Institute (IIS Aragón), Zaragoza, Spain.; Immunology Department, University Hospital Lozano Blesa, Zaragoza, Spain.; Department of Microbiology, Pediatrics, Radiology and Public Health, University of Zaragoza, Zaragoza, Spain.; Aragon Nanoscience institute, Zaragoza, Spain.; Aragon Materials Science Institute, Zaragoza, Spain., Ocariz M; Medical Oncology Department, University Hospital Lozano Blesa, Zaragoza, Spain.; Aragon Health Research Institute (IIS Aragón), Zaragoza, Spain., Pardo J; Aragon Health Research Institute (IIS Aragón), Zaragoza, Spain.; ARAID Foundation (IIS Aragón), Zaragoza, Spain.; Microbiology, Preventive Medicine and Public Health Department, Medicine, University of Zaragoza, Zaragoza, Spain.; Biomedical Research Center in Bioengineering, Biomaterials and Nanomedicine Network (CIBER-BBN), Madrid, Spain., Ramírez A; Nanotoxicology and Immunotoxicology Unit (IIS Aragón), Zaragoza, Spain., Sesma A; Medical Oncology Department, University Hospital Lozano Blesa, Zaragoza, Spain.; Aragon Health Research Institute (IIS Aragón), Zaragoza, Spain., Torres-Ramón I; Medical Oncology Department, University Hospital Lozano Blesa, Zaragoza, Spain.; Aragon Health Research Institute (IIS Aragón), Zaragoza, Spain., Paño JR; Aragon Health Research Institute (IIS Aragón), Zaragoza, Spain.; Infectious Disease Department, University Hospital Lozano Blesa, Zaragoza, Spain.
Publikováno v: Infection and immunity [Infect Immun] 2021 Aug 16; Vol. 89 (9), pp. e0066520. Date of Electronic Publication: 2021 Aug 16.
Zobrazit plný text záznamu
10
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje